Description MIRVASO® (brimonidine) topical gel, 0.33%* is an alpha adrenergic agonist indicated for the topical treatment of persistent (nontransient) facial erythema of rosacea in adults 18 years of age or older. MIRVASO Topical Gel is a temporary treatment for facial redness MIRVASO Topical Gel may dramatically reduce your symptoms, but it won’t prevent or cure facial redness. Your redness will return after the effect of MIRVASO Topical Gel wears off. MIRVASO Topical Gel is available in the MIRVASO Topical Gel Pump The delivery system of the MIRVASO Topical Gel pump gives a consistent dose at each use. Exposure to triggers could make your symptoms worse Avoid your triggers, even if you are using MIRVASO Topical Gel as directed.
